Boltz Bio Joins AAlphaBio-Led AI Drug Discovery Data Consortium
GabriCorso · x · 2026-07-22
Boltz Bio announced it is a founding member of a new data consortium organized by AAlphaBio. The consortium includes major pharmaceutical and AI design companies such as GSK, Cradle Bio, and Dyno Therapeutics to advance AI-driven drug discovery.
Related event: Boltz Bio Joins AI Drug Discovery Data Consortium(4 posts)→
More from Companies & People
- X drama: Anthropic researchers accused of spying on academic customers and racing them to results — basedjensen · 2026-09-11
- Investor argues Palantir-Nvidia partnership should slash Anthropic's IPO valuation — pdamodaran · 2026-09-11
- PyTorch Day Korea 2026 launches first offline conf, CFP closes Sept 13 — PyTorch · 2026-09-11
- Class action accuses Anthropic of overselling Claude subscriptions with deceptive usage multipliers — The Decoder · 2026-09-11
- AI post-training and evals jobs pay up to $850K, with median offers at $210K–$325K — FinanceYF5 · 2026-09-11
- 89% of firms use AI, only 6% see significant ROI — the busywork illusion — mikeflache · 2026-09-11